A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS
IsraelCompletedPHASE2
Conditions
Amyotrophic Lateral Sclerosis · ALS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Lawson Health Research Institute, London, Ontario, Canada
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
IRCCS Istituti clinici Maugeri, Milan, Italy
A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy
View source on ClinicalTrials.gov(opens in a new tab)
No study contact email or phone is listed for this trial.